Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Interventional Radiology(Electronic Edition) ›› 2019, Vol. 07 ›› Issue (03): 251-254. doi: 10.3877/cma.j.issn.2095-5782.2019.03.016

Special Issue:

• Review • Previous Articles     Next Articles

Research progress in interventional therapy for treatment of Budd-Chiari syndrome

Qingmiao Shi1, Xin Yuan1, Juan Li1, Zujiang Yu1,()   

  1. 1. Department of Infection Disease, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
  • Received:2019-04-09 Online:2019-08-01 Published:2019-08-01
  • Contact: Zujiang Yu
  • About author:
    Corresponding author: Yu Zujiang, Email:

Abstract:

Budd-Chiari syndrome (BCS) is an infrequent disease with multiple causes. Its clinical manifestations could be asymptomatic, chronic or fulminant. The treatment strategy for BCS should be taken step by step basing on the patient's condition. In recent years, endovascular interventional therapy technology has developed rapidly, relying on its advantages such as safe and minimally invasive, it has became the first treatment choice for BCS. Among them, percutaneous transluminal angioplasty (PTA) and endovascular stent implantation (ESI) and transjugular intrahepatic portosystemic shunt (TIPS) gradually play an important role in the treatment for BCS. This article will review the research progress of interventional therapy for BCS.

Key words: Budd-Chiari syndrome, interventional therapy, balloon, stent, portal shunt, research progress

京ICP 备07035254号-20
Copyright © Chinese Journal of Interventional Radiology(Electronic Edition), All Rights Reserved.
Tel: 0756-2528259 E-mail: zhjrfsx@163.com
Powered by Beijing Magtech Co. Ltd